Clinical Characteristics of Our Female Patients with Fibromyalgia Syndrome: Our Fibromiyalgia Patiens Clinical Characters

Yasemin Yumuşakhuylu; Hanife Çağlar Yağcı; Melisa Zengin; Belgin Erhan

doi:10.28982/josam.8071

Authors

Yasemin Yumuşakhuylu Istanbul Medeniyet University Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Kadıköy, Istanbul, Turkey https://orcid.org/0000-0001-6843-1614
Hanife Çağlar Yağcı Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Department of Physical Medicine and Rehabilitation, Kadıköy, Istanbul, Turkey https://orcid.org/0000-0002-7142-6610
Melisa Zengin Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Department of Physical Medicine and Rehabilitation, Kadıköy, Istanbul, Turkey https://orcid.org/0009-0005-4462-5154
Belgin Erhan Istanbul Medeniyet University Faculty of Medicine, Department of Physical Medicine and Rehabilitation, Kadıköy, Istanbul, Turkey https://orcid.org/0000-0003-4055-8685

DOI:

https://doi.org/10.28982/josam.8071

Keywords:

demographic characteristics, depression, fibromyalgia syndrome, quality of life, comorbidities, Fibromyalgia Impact Questionnaire

Abstract

Objective: To investigate the clinical characteristics of patients diagnosed with Fibromyalgia Syndrome (FMS) presenting to our clinic in order to identify issues in healthcare services and other solvable areas.

Method: Between 01.12.2023 and 31.12.2023, female patients admitted to the Physical Medicine and Rehabilitation outpatient clinic of Göztepe Prof. Dr. Süleyman Yalçın City Hospital who were diagnosed with FMS according to the 2013 ACR modified diagnostic criteria were included in the study. Demographic characteristics of the patients including height, weight, educational status, marital status, occupation, habits, comorbidities and medications were recorded. Fibromyalgia Impact Questionnaire (FQI) and Beck Depression Inventory (BDI) were completed by all participants. Ethics committee approval was obtained for the study (decision no: 2021/0357)

Results: A total of 44 female FMS patients were included in the study. Our patients were aged between 26-64 years (mean: 46.65±7.63). ). Body mass index (BMI) was 16.65-45.72 (mean: 28.82±6.11) While 20.5% of the patients had normal BMI, 75% were in the overweight or obese category. The majority of the participants were primary school graduates (50%), married (84.1%) and housewives (59.1%). 34% of our patients were active smokers. 52.3% of the patients had a chronic comorbidity. When the presence of chronic diseases such as Chronic Obstructive Pulmonary Disease (COPD), Diabetes Mellitus (DM), Coronary Artery Disease (CAD), Hypertension (HTN) was questioned, the most common comorbidity was DM with 25% and hypertension with 18.2%. 95.5% of our patients were fully independent in activities of daily living and ambulated without assistance. According to FQI results, 23.6% of the patients were severely and 45.5% were moderately affected. According to the BDI results, 22.7% of the patients had severe depression and 36.4% had moderate depression.

Conclusion: Fibromyalgia patients need not only pain treatment but also evaluation and treatment of comorbid conditions. When we examine the patients in our study, it is seen that there is a serious depression and weight control problem. A multidisciplinary team including psychiatrists and dieticians will be more effective in the treatment of this disease. In addition, considering that most of our participants were married and graduated from primary school, further studies may be useful to evaluate whether social problems accompany the disease. It is important that physicians increase their awareness of the disease and manage patients with a multidisciplinary approach.

Downloads

Download data is not yet available.

References

Bellato E, Marini E, Castoldi F, Barbasetti N, Mattei L, Bonasia DE, et al. Fibromyalgia syndrome: etiology, pathogenesis, diagnosis, and treatment. Pain Res Treat. 2012;2012:426130. doi: 10.1155/2012/426130. DOI: https://doi.org/10.1155/2012/426130

Clauw DJ. Fibromyalgia: an overview. Am J Med. 2009;122(12 Suppl):S3-S13. doi: 10.1016/j.amjmed.2009.09.006. DOI: https://doi.org/10.1016/j.amjmed.2009.09.006

Pagano T, Matsutani LA, Ferreira EA, Marques AP, Pereira CA. Assessment of anxiety and quality of life in fibromyalgia patients. Sao Paulo Med J. 2004;122(6):252-8. doi: 10.1590/s1516-31802004000600005. DOI: https://doi.org/10.1590/S1516-31802004000600005

Price DD, Staud R. Neurobiology of fibromyalgia syndrome. J Rheumatol Suppl. 2005;75:22-8. PMID: 16078357.

Petersel DL, Dror V, Cheung R. Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res.2011;89(1):29-34. doi: 10.1002/jnr.22512. DOI: https://doi.org/10.1002/jnr.22512

Häuser W, Burgmer M, Köllner V, Schaefert R, Eich W, Hausteiner-Wiehle C, et al. [Fibromyalgia syndrome as a psychosomatic disorder - diagnosis and therapy according to current evidence-based guidelines]. Z Psychosom Med Psychother. 2013;59(2):132-52. doi: 10.13109/zptm.2013.59.2.132. DOI: https://doi.org/10.13109/zptm.2013.59.2.132

Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med. 2007;146(10):726-34. doi: 10.7326/0003-4819-146-10-200705150-00006. DOI: https://doi.org/10.7326/0003-4819-146-10-200705150-00006

Epstein SA, Kay G, Clauw D, Heaton R, Klein D, Krupp L, et al. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics. 1999;40(1):57-63. doi: 10.1016/s0033-3182(99)71272-7. DOI: https://doi.org/10.1016/S0033-3182(99)71272-7

The World Health Organization Quality of Life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;41(10):1403-9. doi: 10.1016/0277-9536(95)00112-k. DOI: https://doi.org/10.1016/0277-9536(95)00112-K

Campos RP, Vázquez MIR. Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated. Clin Rheumatol. 2012;31:347-55. doi: 10.1007/s10067-011-1870-7. DOI: https://doi.org/10.1007/s10067-011-1870-7

Sezgin Özcan D, Aras M, Köseoğlu BF, Şentürk Güven Ş. Quality of life and associated conditions in women with fibromyalgia syndrome. Osteoporoz. 2013;19:0-0. doi: 10.4274/tod.38258 DOI: https://doi.org/10.4274/tod.38258

Vincent A, Lahr BD, Wolfe F, Clauw DJ, Whipple MO, Oh TH, et al. Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken).2013;65(5):786-92. doi: 10.1002/acr.21896. DOI: https://doi.org/10.1002/acr.21896

Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract. 2007;61(9):1498-508. doi: 10.1111/j.1742-1241.2007.01480.x. DOI: https://doi.org/10.1111/j.1742-1241.2007.01480.x

Lamotte M, Maugars Y, Le Lay K, Taïeb C. Health economic evaluation of outpatient management of fibromyalgia patients and the costs avoided by diagnosing fibromyalgia in France. Clin Exp Rheumatol. 2010;28(6 Suppl):S64-S70. DOI: https://doi.org/10.1016/S1098-3015(10)75168-8

Grodman I, Buskila D, Arnson Y, Altaman A, Amital D, Amital H. Understanding fibromyalgia and its resultant disability. IMAJ-Israel Med Assoc J. 2011;13(12):769. PMID: 22332450.

D'Onghia M, Ciaffi J, Ruscitti P, Cipriani P, Giacomelli R, Ablin JN, Ursini F. The economic burden of fibromyalgia: A systematic literature review. Semin Arthritis Rheum. 2022;56:152060. doi: 10.1016/j.semarthrit.2022.152060. DOI: https://doi.org/10.1016/j.semarthrit.2022.152060

Nguyen VC, Park J. Relationships between demographic factors and chronic conditions with disease severities. Int J Environ Res Public Health. 2021;18(21):11469. doi: 10.3390/ijerph182111469. DOI: https://doi.org/10.3390/ijerph182111469

Sarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000;20(1):9-12. doi: 10.1007/s002960000077. DOI: https://doi.org/10.1007/s002960000077

Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R, et al. Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken). 2014;66:1364-73. doi: 10.1002/acr.22301. DOI: https://doi.org/10.1002/acr.22301

Dernek B. Fibromiyalji Sendromu Hastalarının İşlevsellik, Yetiyitimi ve Sağlığın Uluslararası Sınıflandırılması ICF Kapsamında Değerlendirilmesi: Pilot Çalışma. Acıbadem Univ Health Sci J. 2020;1:160-6. DOI: https://doi.org/10.31067/0.2020.255

Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28. DOI: https://doi.org/10.1002/art.1780380104

Cacace E, Ruggiero V, Anedda C, Denotti A, Minerba L, Perpignano G. Quality of life and associated clinical distress in fibromyalgia. Reumatismo. 2006/09/30;58. doi: 10.4081/reumatismo.2006.226. DOI: https://doi.org/10.4081/reumatismo.2006.226

Aparicio VA, Ortega FB, Carbonell-Baeza A, Cuevas AM, Delgado-Fernández M, Jonatan R. Anxiety, depression and fibromyalgia pain and severity. Behav Psychol. 2013;21:381.